Skip to main content
OpenTrials

Clinical trial condition

Granulomatous Disease, Chronic

Explore clinical trials studying Granulomatous Disease, Chronic. Study availability and eligibility vary by location and protocol.

52 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

Granulomatous Disease, Chronic trial results

Not yet recruiting

Lentiviral Gene Therapy for CGD

NCT03645486

Conditions
Chronic Disease, Chronic Granulomatous Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +12 more
Locations
  • Shenzhen Geno-immune Medical Institute Shenzhen, Guangdong, China
View Trial Details
Enrolling by invitation

A Study of the Safety and Efficacy of Prime Editing (PM359) in Participants With p47phox Autosomal Recessive Chronic Granulomatous Disease (CGD )

NCT06559176

Conditions
Chronic Disease, Chronic Granulomatous Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +12 more
Locations
  • University of California Los Angeles Medical Center Los Angeles, California, United States
  • NIH Clinical Center Bethesda, Maryland, United States
  • The Children's Hospital at Tristar Medical Group/Sarah Cannon Center for Blood Cancers Nashville, Tennessee, United States
  • CHU - Sainte Justine Hospital Montreal, Quebec, Canada
View Trial Details
Active, not recruiting

Study of EN-374 Gene Therapy in Participants With X-Linked Chronic Granulomatous Disease

NCT06876363

Conditions
Chronic Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Disease Attributes, +12 more
Locations
  • University of California, Los Angeles Los Angeles, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Johns Hopkins All Children's Hospital St. Petersburg, Florida, United States
  • Boston Children's Hospital Boston, Massachusetts, United States
View Trial Details
Active, not recruiting

Early Check: Expanded Screening in Newborns

NCT03655223

Conditions
17 Alpha-Hydroxylase Deficiency, 3-Hydroxy-3-Methylglutaric Aciduria, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, +456 more
Locations
  • RTI International Research Triangle Park, North Carolina, United States
View Trial Details

Related conditions